梅里埃中国

生物梅里埃公司创建于1963年，公司依赖自身的科技研究和工业生产资源，始终致力于开发作为医疗和工业用途的体外诊断产品。 集团专门设计、开发、生产和推广应用在临床和工业的系统。生物梅里埃的诊断系统是由试剂、仪器和软件组成，主要为传染病、工业微生物控制、心血管病和肿瘤病等四个主要策略性领域进行设计。在2010年，公司销售额已达到13亿5千7百万欧元，共有18个生产基地和11个研究中心，分布于欧洲、北美洲和南美洲。至2011年集团员工已超过7，000人，遍布全球39个国家和地区。
生物梅里埃公司产品有两个主要应用领域：临床和工业。临床市场占总销售额的85%，而工业市场占15%。工业的应用领域主要集中在食品、药品和化妆品的微生物分析，其市场增长非常迅速。

生物梅里埃是全球体外诊断领域的第七大生产商。

World leader in the field of in vitro diagnostics for over 55 years, bioMérieux conceives, develops,

produces and markets diagnostics solutions (systems, reagents, software and services) intended

for clinical and industrial applications, which determine the origin of a disease or a contamination

to improve the health of patients and insure consumer safety.

bioMérieux is present in 43 countries and serves more than 160 countries with the support of a

large network of distributors. Its corporate headquarters are located in Marcy l’Etoile, near Lyon,

in France.

Joining bioMérieux, is choosing to join an innovative company with a long term vision, committed

to the service of public health and carried out with a humanistic corporate culture.

Our Group offers numerous possibilities: so come and join the 11,200 bioMérieux

employees who already identify with these values!